Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.
about
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVFuture of liver disease in the era of direct acting antivirals for the treatment of hepatitis CHepatitis C-related hepatocellular carcinoma in the era of new generation antivirals.Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis CIs elimination of hepatitis C from the UK by 2030 a realistic goal?Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression?Increased incidence of liver cancer after successful DAA treatment of chronic hepatitis C: Fact or fiction?Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older.Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens.Hepatitis C Virus Clearance in Older Adults.Hepatitis C virus eradication with direct antiviral agents and liver cancer recurrence: Is the best the enemy of the good?Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis.Hepatocellular carcinoma and direct-acting antivirals: A never ending story?What do clinicians need to watch for with direct-acting antiviral therapy?Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.The impact of antiviral therapy on hepatocellular carcinoma epidemiology
P2860
Q28079826-EF6A6798-6C97-4855-A02F-7F2A4DB85AF2Q30235178-E7FE458A-9407-42A1-A267-35E095FF9883Q36306768-38CC2E4C-CB3C-45C5-B83A-22CBFDDCB152Q37322478-D5222AFA-C67C-4360-A43F-785A0C04F665Q38729888-BC52CEB7-47DC-4869-9026-851BAEFD0057Q38758591-827523B7-263C-409D-A325-9034D99F61BBQ38763705-130A8332-FF38-4048-931B-62B36462DFD4Q39099624-E50562C2-820D-40C0-A848-CC13482ABCB3Q40238687-660D6C33-7345-48D8-8E45-89FF1AA32AD0Q40420373-392C20AB-C4DA-498B-88F4-D0ADDB13ACB4Q40557601-51416123-1440-43CD-B22C-3FDE30833368Q41931578-CB3EAB75-4419-480A-AC22-24A0D9D1743CQ45324869-7BC05937-9506-4EBB-988E-521EF60BCDEDQ45327946-E7208ACC-DC2B-4CE8-92DE-191EB732B8D9Q47569554-17BD0943-AAFB-4990-AAFB-76A703F52270Q48092639-4B072437-A2C1-4DEF-B35E-1CFEA686C8E3Q52327014-DF6F755D-F4B0-4231-B4D9-59BBE157F637Q55348708-F66CAAEC-63D0-487A-81BA-FC460AC7F352Q57301376-C0B27608-88EA-491D-AC20-919A059EAF96
P2860
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Survival of patients with HCV ...... lar to the general population.
@en
type
label
Survival of patients with HCV ...... lar to the general population.
@en
prefLabel
Survival of patients with HCV ...... lar to the general population.
@en
P2093
P50
P1476
Survival of patients with HCV ...... lar to the general population.
@en
P2093
Alessio Aghemo
Andrea Crosignani
Antonio Craxí
Luigi Roffi
Massimo Colombo
Mauro Viganò
Savino Bruno
Vincenzo Boccaccio
Vito Di Marco
P304
P356
10.1016/J.JHEP.2016.01.034
P577
2016-03-23T00:00:00Z